Clinical Trial

Use of Sildenafil for Treatment of Urinary Incontinence

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The investigators goal is to develop medical treatments for stress/mixed urinary incontinence. Sildenafil has been shown to improve blood flow as well as muscle mass and strength and to decrease muscle fatigue. The investigators believe that it will improve muscular atrophy in the pelvic floor, thus improving symptoms of urinary incontinence related to pelvic floor dysfunction.
Protocol Amendment History 1 change
minor Completion pushed: 2027-07 -> 2028-07 2026-08-07
Trial Details
NCT Number NCT02983461
Lead Sponsor The University of Texas Medical Branch, Galveston
Conditions Urinary Incontinence
Enrollment 24 participants
Start Date 2017-03-10
Primary Completion 2020-03-01 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-06